FACSX | JVMCX | FACSX / JVMCX | |
Total Expense Ratio | 1.88 | 1.85 | 102% |
Annual Report Gross Expense Ratio | 1.97 | 1.86 | 106% |
Fund Existence | 27 years | 14 years | - |
Gain YTD | 7.625 | 11.818 | 65% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 1000 | 250% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 378M | 24.2B | 2% |
Annual Yield % from dividends | 0.18 | 0.00 | - |
Returns for 1 year | 4.74 | 1.84 | 258% |
Returns for 3 years | 14.79 | 19.79 | 75% |
Returns for 5 years | 62.43 | 51.15 | 122% |
Returns for 10 years | 66.79 | 45.25 | 148% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
VTN | 10.73 | 0.14 | +1.32% |
Invesco Trust for Investment Grade New York Municipals | |||
BBSB | 99.29 | -0.04 | -0.04% |
JPMorgan BetaBuilders U.S. TrsBd1-3YrETF | |||
PBUS | 66.11 | -0.03 | -0.05% |
Invesco MSCI USA ETF | |||
IGE | 48.12 | -0.30 | -0.62% |
iShares North American Natural Res ETF | |||
GSKH | 57.13 | -0.87 | -1.50% |
GSK PLC ADRHEDGED GSKH |